The Clinical Oncology Specialist (COS) – Gastrointestinal (GI) is a high-impact, clinical sales role that leverages deep oncology, pathology, and molecular diagnostics expertise to drive the adoption and utilization of Natera's advanced oncology portfolio, with a primary focus on Signatera in GI malignancies (including Colorectal, Pancreatic, Esophageal, Gastric, and Hepatobiliary cancers ). Drive GI Clinical Adoption: Execute targeted sales strategies and deliver approved clinical marketing messages to key opinion leaders (KOLs), physicians, and hospital stakeholders to influence test adoption and volume growth across GI tumor types (Colorectal, Pancreatic, Esophageal, Gastric, and Hepatobiliary) .